Zhongshan Hospital Cardiovascular Imaging Registry

The purpose of this registry is to establish a multi-modality cardiac image database including coronary angiography (CAG), optical coherence tomography (OCT), intravascular ultrasound (IVUS), computed tomography angiograms (CTA) and cardiac magnetic resonance imaging (CMR) for future studies. The main goal of this collaboration is to create a resource for advanced research on atherosclerosis through image analysis.

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Conditions

Atherosclerosis Arterial Occlusive Diseases Arteriosclerosis Cardiovascular Diseases Vascular Diseases

Age range

14 year–99 year

Sex eligibility

All sexes

Study type

Observational

About this study

This registry plans to establish a multi-modality cardiac image database including coronary angiography (CAG), optical coherence tomography (OCT), intravascular ultrasound (IVUS), computed tomography angiograms (CTA) and cardiac magnetic resonance imaging (CMR) for future studies. Patients who underwent CAG or CTA during Aug 1st, 2025 and Dec 31st, 2035 at Zhongshan Hospital will be included in this registry. In addition, patients with CTA or at least one of OCT/IVUS/CMR between Jan 1st, 2012 and Jul 31st, 2025 will be retrospectively registered. Subgroups of these patients will have OCT/IVUS/CMR as according to their clinical presentations and requests from their doctors in charge. This registry aims to create a resource for advanced imaging research on atherosclerosis.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Patients with potential cardiovascular disease(s) (CVD) or diagnosed with CVD who were referred to CTA and/or CAG.
Optional cardiac imagings, namely OCT/IVUS/CMR were up to doctors in charge and not mandatory.

Exclusion criteria

Patient without any of the above mentioned cardiac imaging record.

Treatment and study plan

Cardiac imaging

Other

Patients who underwent CTA or CAG, with or without other cardiac imaging modelities (OCT, IVUS, or CMR) will be enrolled in this registry.

Other names: CAG/CTA/OCT/IVUS/CMR

Primary outcomes

MACE

Time frame: 10 years

Major adverse cardiac events

Study contacts

Contact information is provided by the study sponsor or research team.

Chenguang Li, MD, PhD

CONTACT

[email protected]

8602164041990

Sponsors and collaborators

Lead sponsor

Shanghai Zhongshan Hospital

Other

Registry information

Important dates

Study start: 2025
Primary completion: 2035
Study completion: 2045
First posted: Jul 23, 2025
Registry last updated: Jul 30, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Recruiting